June 7, 2020

Dramatic Improvement in Dyspnea in A Non-Small Cell Lung Cancer Patient, Following Administration of Anti-IL-6R

Currently in most Lung Cancer cases in which there is tumor progression, the molecular approach is to search for new mutations, usually utilizing circulating free DNA. There are however cases where a trauma, such as an operation, is followed by rapid tumor progression and the key for treatment in these cases, might be the search

Dramatic Improvement in Dyspnea in A Non-Small Cell Lung Cancer Patient, Following Administration of Anti-IL-6R Read More »